« Back
Home /
Pyridoxine

Pyridoxine

Item no.	HY-B1328-50mg
Manufacturer	MedChem Express
CASRN	65-23-6
Amount	50 mg
Quantity options	100 mg 10 mM/1 mL 25 mg 500 mg 50 mg
Category	Reagents & Chemicals Biochemicals
Type	Chemicals
Specific against	other
Purity	99.98
Citations	[1]Li C, et al. Pyridoxine exerts antioxidant effects in cell model of Alzheimer's disease via the Nrf-2/HO-1 pathway. Cell Mol Biol (Noisy-le-grand). 2018 Jul 30;64(10):119-124. Cancer Lett. 2020 Nov 1;492:96-105.\|Microbiome. 2019 Mar 20;7(1):43. \|Molecules. 2023 Apr 11, 28(8), 3375.\|Nat Commun. 2020 Feb 18;11(1):941. \|Laurea Magistrale in Biomedical Engineering, Politecnico di Milano. 2019 Jun.\|Nature. 2024 Dec 18.
Smiles	OCC1=C(CO)C(O)=C(C)N=C1
ECLASS 10.1	32160000
ECLASS 11.0	32160000
UNSPSC	12000000
Alias	Pyridoxol
Shipping Condition	Room temperature
Available
Manufacturer - Type	Natural Products
Manufacturer - Applications	Neuroscience-Neurodegeneration
Manufacturer - Targets	Endogenous Metabolite; Keap1-Nrf2
Shipping Temperature	Room Temperature
Storage Conditions	4°C (Powder, protect from light)
Molecular Weight	169.18
Product Description	Pyridoxine (Pyridoxol) is a pyridine derivative. Pyridoxine exerts antioxidant effects in cell model of Alzheimer's disease via the Nrf-2/HO-1 pathway.
Manufacturer - Research Area	Neurological Disease; Cancer
Solubility	DMSO: 100 mg/mL (ultrasonic)
Manufacturer - Pathway	Metabolic Enzyme/Protease; NF-κB
Isoform	Human Endogenous Metabolite; Microbial Metabolite
Clinical information	Launched

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-B1328-50mg-safety-datasheet.pdf